In a rare M&A move, Amgen proposes to acquire partner Nuevolution

In what would be its first acquisition since 2015, Amgen offered on Wednesday to buy Copenhagen-based small molecule discovery company Nuevolution for about $167 million in cash.

Amgen Inc. (NASDAQ:AMGN)

Read the full 294 word article

How to gain access

Continue reading with a
two-week free trial.